Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin B Begg

Showing results (121-130 of 184) with videos related to

Pageof 19
Sort By:
JCO Precision Oncology|March 17, 2023
Pathway Alterations in Stage II/III Primary MelanomaCaroline E Kostrzewa, Li Luo, Arshi Arora, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Improving Accuracy of Somatic Mutation Profiling in Large Epidemiologic Studies: Addressing Cases without Matched Normal SamplesArshi Arora, Li Luo, Caroline E Kostrzewa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
DNA damage and repair capacity in patients with lung cancer: prediction of multiple primary tumorsIrene Orlow, Bernard J Park, Urvi Mujumdar, et al.
Cancer Causes & Control : CCC|December 4, 2004
Familial aggregation of melanoma risks in a large population-based sample of melanoma casesColin B Begg, Amanda Hummer, Urvi Mujumdar, et al.
JNCI Cancer Spectrum|January 12, 2025
Sex differences in melanoma survival-a GEM studyTharani Murali, Matthew Schwartz, Adam Z Reynolds, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 18, 2007
Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanomaNancy E Thomas, Sharon N Edmiston, Audrey Alexander, et al.
JAMA Network Open|March 22, 2022
Validation of a Population-Based Data Source to Examine National Cancer Clinical Trial ParticipationAngela K Green, Sara M Tabatabai, Xing Bai, et al.
BMC Medical Research Methodology|December 24, 2014
Genomic investigation of etiologic heterogeneity: methodologic challengesColin B Begg, Venkatraman E Seshan, Emily C Zabor, et al.
International Journal of Epidemiology|March 25, 2006
A design for cancer case-control studies using only incident cases: experience with the GEM study of melanomaColin B Begg, Amanda J Hummer, Urvi Mujumdar, et al.
Cancer Epidemiology|May 27, 2011
Sun exposure, vitamin D receptor polymorphisms FokI and BsmI and risk of multiple primary melanomaRochelle Mandelcorn-Monson, Loraine Marrett, Anne Kricker, et al.
Pageof 19

Showing results (121-130 of 184) with videos related to

Sort By:
Pageof 19
JCO Precision Oncology|March 17, 2023
Pathway Alterations in Stage II/III Primary MelanomaCaroline E Kostrzewa, Li Luo, Arshi Arora, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Improving Accuracy of Somatic Mutation Profiling in Large Epidemiologic Studies: Addressing Cases without Matched Normal SamplesArshi Arora, Li Luo, Caroline E Kostrzewa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
DNA damage and repair capacity in patients with lung cancer: prediction of multiple primary tumorsIrene Orlow, Bernard J Park, Urvi Mujumdar, et al.
Cancer Causes & Control : CCC|December 4, 2004
Familial aggregation of melanoma risks in a large population-based sample of melanoma casesColin B Begg, Amanda Hummer, Urvi Mujumdar, et al.
JNCI Cancer Spectrum|January 12, 2025
Sex differences in melanoma survival-a GEM studyTharani Murali, Matthew Schwartz, Adam Z Reynolds, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 18, 2007
Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanomaNancy E Thomas, Sharon N Edmiston, Audrey Alexander, et al.
JAMA Network Open|March 22, 2022
Validation of a Population-Based Data Source to Examine National Cancer Clinical Trial ParticipationAngela K Green, Sara M Tabatabai, Xing Bai, et al.
BMC Medical Research Methodology|December 24, 2014
Genomic investigation of etiologic heterogeneity: methodologic challengesColin B Begg, Venkatraman E Seshan, Emily C Zabor, et al.
International Journal of Epidemiology|March 25, 2006
A design for cancer case-control studies using only incident cases: experience with the GEM study of melanomaColin B Begg, Amanda J Hummer, Urvi Mujumdar, et al.
Cancer Epidemiology|May 27, 2011
Sun exposure, vitamin D receptor polymorphisms FokI and BsmI and risk of multiple primary melanomaRochelle Mandelcorn-Monson, Loraine Marrett, Anne Kricker, et al.
Pageof 19